Shilajit

Safety Risk (1.8/5.0) Purified shilajit has one of the cleaner safety profiles in the traditional supplement category. Only two serious case reports exist in the modern literature (pseudohyperaldosteronism and one cognitive/neurological ER presentation) across centuries of global use, and neither is linked to PrimaVie-grade purified extract; Stohs 2014 reviewed the modern safety record and supports the low-risk rating. No deaths reported. The real-world risk is extrinsic: unpurified raw shilajit concentrates arsenic, lead, cadmium, and mercury because the same mineral-chelating matrix that delivers micronutrients also delivers contaminants. Hormonal shifts (testosterone and FSH increase) make shilajit unsuitable for hormone-sensitive cancers, pregnancy, lactation, and hemochromatosis. Score 1.8 reflects purified product safety; raw unpurified resin from unverified sources would score materially worse.

Side Effect Profile (1.8/5.0) Well-tolerated at the 300-500 mg clinical range. GI effects (nausea, loose stool) and mild headaches in the first 1-3 days are the most commonly reported symptoms, typically described as a detox window in community forums. Anxiety above 500 mg is reported in sensitive users, consistent with the gonadotropic and mild adaptogenic stimulation profile. Aggregate community sentiment runs approximately 60% positive, 25% neutral or no effect, 15% negative; negative experiences cluster in users consuming unpurified resin or dosing beyond 500 mg/day. No cases of rebound fatigue or acute withdrawal have been reported after cessation. Overall side effect burden is low relative to peers in the testosterone-support category.

Financial Cost (2.5/5.0) Pricing is moderate and depends heavily on form. Purified standardized PrimaVie capsules run approximately $15-25/month at 300-500 mg/day through retailers like Nootropics Depot. Quality resin such as Purblack or comparable tested Altai material runs $50-100 per jar, with each jar lasting 4-8 weeks at normal dosing, which puts monthly cost in a similar $25-50 band. Bulk unbranded resin is cheaper but fails third-party testing for heavy metals at high enough rates to not be a legitimate cost saving. At a conservative $25-50/month for legitimate purified product, shilajit lands in the $30-100 cost anchor band on the BioHarmony scale. Not cheap, not expensive, in line with the broader adaptogen and testosterone-support category.

Time/Effort Burden (1.5/5.0) Capsule form is effectively zero effort: one to two capsules with water on an empty stomach in the morning, total elapsed time under 15 seconds. Resin form is where the effort score is earned. Dissolving a pea-sized portion of sticky black resin in warm water takes 2-3 minutes, the taste is assertively bitter and mineral-heavy, and the resin stains whatever it touches. Traditional cycling protocols (6-8 weeks on / 1-2 weeks off) add light tracking overhead. No appointments, no monitoring labs required beyond the optional 90-day semen analysis or testosterone panel. For the default capsule route, burden is trivial; the score is elevated slightly to reflect the resin pathway many users still prefer.

Opportunity Cost (1.5/5.0) Shilajit complements rather than crowds out other interventions. The fulvic-acid carrier matrix actively enhances absorption of co-ingested fat-soluble and mineral-based supplements; Surapaneni 2012 directly showed CoQ10 transport is augmented. No known interference with peptides, adaptogens, nootropics, sleep stack, or exercise programming. The one trade-off is budget: the $25-50/month footprint competes with other mineral, adaptogen, or testosterone-support spend. Compared with peers in the testosterone and fertility category (tongkat ali, fadogia, clomiphene, TRT itself), shilajit integrates more cleanly with a broader stack. No appointments or lab work displaces other efforts, which keeps opportunity cost genuinely low.

Dependency/Withdrawal (1.2/5.0) There is no documented tolerance, downregulation, or physical withdrawal syndrome for shilajit. The mechanism is delivery-matrix plus trace-mineral plus mild gonadotropic support, not a direct hormone or neurotransmitter agonist, so chronic dosing does not desensitize a receptor target or crash an axis. Pandit 2016 and Biswas 2010 both used 90-day continuous dosing without reported adaptation, and Durgam 2022 ran 48 weeks without a plateau or tapering requirement. Traditional Ayurvedic cycling (6-8 weeks on / 1-2 weeks off) is conservative custom, not biology. Users who stop simply return toward baseline over weeks as acute hormonal effects wash out. The small residual score reflects that any gonadotropic support deserves a nonzero entry.

Reversibility (1.2/5.0) Shilajit is fully reversible with no known permanent physiological changes. The testosterone and FSH shifts from Pandit 2016 and Biswas 2010 revert toward baseline within weeks of stopping, consistent with the half-life of the circulating effect rather than structural recalibration. Bone density gains from Durgam 2022 and collagen/ECM upregulation from Das 2016 likely persist for a while after cessation because the tissue change itself is slow to remodel, but nothing about the intervention forecloses future options. Unlike TRT or prescription hormone therapy, there is no HPTA suppression, no endogenous shutdown, no surgical or permanent component. Stop anytime, with the understanding that the acute hormonal and energy benefits will fade over weeks to months. This is a fully reversible chronic supplement.